<?xml version="1.0" encoding="UTF-8"?>
<p>The World Health Organization (WHO) identified viral hepatitis as a global health problem and set a goal to eliminate viral hepatitis by 2030 [
 <xref rid="pntd.0007586.ref026" ref-type="bibr">26</xref>]. Even though an effective low-cost hepatitis E vaccine is available [
 <xref rid="pntd.0007586.ref027" ref-type="bibr">27</xref>,
 <xref rid="pntd.0007586.ref028" ref-type="bibr">28</xref>], the vaccine is not recommended for general use in endemic countries, largely because the burden of disease is not quantified and so it is unclear if use of the vaccine is appropriate and cost effective [
 <xref rid="pntd.0007586.ref029" ref-type="bibr">29</xref>]. Hepatitis E disease surveillance data are limited to a few high-income countries [
 <xref rid="pntd.0007586.ref030" ref-type="bibr">30</xref>,
 <xref rid="pntd.0007586.ref031" ref-type="bibr">31</xref>]; most of the data from endemic countries are limited to disease outbreak and case series reports.
</p>
